One page, the whole story.
Brooks Laboratories Limited
NSE: BROOKSHealthcare₹180 Cr
“Promoter exodus meets DII lifeline in debt-free pharma shell.”
₹61.26
+0.46%+₹0.28 today
Day low ₹61.00Day high ₹62.40
Market view
our read, in one sentence, with the evidence one tap awayEODconviction recomputed 21:46No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for BROOKStoday. That isn't bearish, just inconclusive.
Why now
today's active factors, delivery data and signals worth reviewingMACD Bearish
MACD is below signal line with negative momentum
Moderatesignal strength
Safety checks
India-specific risk checks.
Business quality
the company itself, each lens scored and explained: a separate read from the Market Setup aboveEODfundamentals to FY26 Q462
Strong business quality
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
1 pass3 neutral0 fail
ValuationFAIR
50
Fairly valued
₹1,000 invested here buys about ₹137 of annual profit. A cheaper stock would buy more.
GrowthSTABLE
41
Steady growth
Returns & MarginsMODERATE
57
Moderate returns
Financial HealthSTRONG
100
Strong balance sheet
Financials
income, balance sheet, cash flow, dividends and corporate actionsEODaudited to FY26Concalls
management commentary from earnings calls, summarisedEODlatest call 31 Mar '26Filings
exchange disclosures summarised as they are filed✦ AI summary: about 30s after the exchangePeers
how the stock stacks up against its closest listed comparablesEODprices end-of-dayData as of 3 Aug 2026, 9:46 pm